| Abstrakt: |
BACKGROUND: Depression and anxiety are both common among individuals with multiple sclerosis (MS) and known to have significant effects on disease symptoms (eg, fatigue, pain), well-being, and quality of life. OBJECTIVES: This pilot investigation examined the effectiveness of a transdiagnostic intervention, the Unified Protocol (UP), in reducing depression and anxiety and associated outcomes among individuals with MS. METHODS: Eighteen participants (12 controls and 6 interventions) completed the study. The intervention consisted of a virtual, 12-week group intervention. RESULTS: Following the intervention, participants reported significant declines in depression, negative affect, and fatigue (Hedges d, 1.30-2.00; P < .05). There were also improvements in coping, benefit finding, and MS self-efficacy (Hedges d, 0.96-1.20; P < .05). These effects were not observed in the control group. CONCLUSIONS: Preliminary findings suggest that the UP intervention holds great promise for not only reducing depression among those with MS but influencing disease symptoms and individuals' coping. [ABSTRACT FROM AUTHOR] |
